ARTICLE | Clinical News
ABP 215: Phase III data
September 28, 2015 7:00 AM UTC
Top-line data from the double-blind, international Phase III 20120265 trial in 642 patients with advanced non-squamous NSCLC showed that 15 mg/kg IV ABP 215 every 3 weeks for up to 6 cycles plus carbo...